Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference [Yahoo! Finance]
Generation Bio Co. - Common stock (GBIO)
Company Research
Source: Yahoo! Finance
for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will participate in a fireside chat at the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9 th at 12:45 p.m. ET. A live webcast of the presentation will be available on the investor section of the company's website at investors.generationbio.com . A replay will be available there for 30 days following the event. About Generation Bio Generation Bio is a biotechnology company working to change what's possible for people living with T cell-driven autoimmune diseases. The company is developing redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of autoreactive T cells, which erroneously recognize and attack the body's own tissues, causing autoimmune diseases. Generation Bio's innovative approach leverages cell-targeted lipid nanoparticles (ctLNP) to selectively deliver sma
Show less
Read more
Impact Snapshot
Event Time:
GBIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GBIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GBIO alerts
High impacting Generation Bio Co. - Common stock news events
Weekly update
A roundup of the hottest topics
GBIO
News
- Generation Bio (NASDAQ:GBIO) had its "market perform" rating reaffirmed by analysts at Citigroup Inc..MarketBeat
- ‘Zombie' biotech buyer Xoma to acquire Generation Bio [Yahoo! Finance]Yahoo! Finance
- Generation Bio (NASDAQ:GBIO) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $5.50 price target on the stock, down previously from $7.00.MarketBeat
- NodThera Appoints Geoff McDonough, M.D., as Independent Board Member [Yahoo! Finance]Yahoo! Finance
- NodThera Appoints Geoff McDonough, M.D., as Independent Board MemberGlobeNewswire
GBIO
Earnings
- 11/5/25 - Beat
GBIO
Sec Filings
- 12/16/25 - Form SC
- 12/15/25 - Form SC14D9C
- 12/15/25 - Form 8-K
- GBIO's page on the SEC website